Glipizide
گلیپیزاید
🍽️ Alimentary Tract And MetabolismSulfonylurea
Market / country: 🇺🇸 USA
Glucotrol (US)
🧮 Dose calculator
Type 2 diabetes mellitus · Regimen source: FDA Glipizide · Dosage and Administration
- • Elderly or liver disease: 2.5 mg. Increase by 2.5–5 mg; max once-daily 15 mg; higher divided before meals; max 40 mg/day. FDA Glipizide · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity; type 1 diabetes, diabetic ketoacidosis. FDA Glipizide · Contraindications
Formulations
- 5 mg tablet — tablet 🇺🇸 USA FDA Glipizide · Package Label
- 10 mg tablet — tablet 🇺🇸 USA FDA Glipizide · Package Label
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Glipizide · Pregnancy
“Pregnancy Category C Glipizide was found to be mildly fetotoxic in rat reproductive studies at all dose levels (5 to 50 mg/kg).”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Glipizide · Nursing Mothers
“Because the potential for hypoglycemia in nursing infants may exist, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Glipizide · Pediatric Use
“Safety and effectiveness in children have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Glipizide · Geriatric Use
“In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA075795
- DailyMed (FDA label)FDA Glipizide
- MedlinePlus (NIH)Glipizide
- WHO ATC/DDDA10BB07
- Darooyab (Iran)Glipizide
🇮🇷 Registered in Iran Darooyab · G-629/Glipizide
Dosage forms with Iranian generic codes, per Darooyab.
- 09242 · GLIPIZIDE 10MG TAB · قرص گلیپیزاید ۱۰ میلیگرم
- 00596 · GLIPIZIDE 5MG TAB · قرص گلیپیزاید ۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Glipizide · Package LabelFDA Glipizide · Dosage and AdministrationFDA Glipizide · Pediatric UseFDA Glipizide · ContraindicationsFDA Glipizide · PregnancyFDA Glipizide · Nursing MothersFDA Glipizide · Geriatric UseFDA Glipizide · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-629/Glipizide
- Clinical review⚠ Unverified